POTOMAVACTM

Neorickettsia Risticii Bacterin

Details

  • POTOMAVAC™️  vaccine to aid in the prevention of potomac horse fever
  • Available monovalent or in combination with rabies vaccine
  • It has been shown to be effective for the vaccination of healthy horses 3 months of age or older against potomac horse fever (equine monocytic ehrlichiosis) due to Neorickettsia risticii
  • Liquid suspension of inactivated Neorickettsia risticii
Features & Benefits

Features

  • Convenience and ease of use

Benefits

  • The safety and efficacy of this product have been demonstrated in controlled vaccination challenge tests and in thorough field evaluations
  • Safe for use for healthy horses, 3 months of age or older
Dosage & Administration

Shake well before use. Aseptically inject 1 mL (1 dose) intramuscularly (IM) into healthy horses 3 months of age or older.

 

Revaccinate with a second 1mL dose intramuscularly 3-4 weeks later.

 

Revaccinate annually or prior to anticipated exposure.

Resources
Safety Information

  • Store at 35-46°F (2-8°C)
  • Do not freeze
  • Do not mix with other products
  • Use entire contents when first opened
  • Shake well before using
  • Do not vaccinate within 21 days before slaughter
  • Contains gentamicin and thimerosal as preservatives

In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results. This product has not been tested in pregnant mares.

 

 

Trademarks

POTOMAVACTM is a trademark of Boehringer Ingelheim Animal Health USA Inc. ©2025 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0108-2021-V2